Core Viewpoint - Kestra Medical Technologies, Ltd. announced an underwritten public offering of 5,500,000 common shares to support various corporate activities including sales, marketing, research, and working capital [1] Group 1: Offering Details - The offering is made under a registration statement filed with the SEC and includes a 30-day option for underwriters to purchase an additional 825,000 shares [1] - The offering is subject to market conditions and there are no guarantees regarding its completion or terms [1] - The proposed offering will be conducted only through a prospectus, with preliminary copies available from designated financial institutions [2][3] Group 2: Company Overview - Kestra Medical Technologies focuses on wearable medical devices and digital healthcare, aiming to improve patient outcomes in cardiovascular disease through innovative monitoring and therapeutic technologies [6]

Company Overview - Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease through monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected [5] Industry Recognition - Kestra Medical Technologies has been recognized as a 2025 Top Workplaces Industry winner by Energage, highlighting its commitment to building a people-first workplace culture [1][2] - The Top Workplaces award is based on feedback from a research-backed employee engagement survey, emphasizing the importance of employee voice and engagement in the workplace [3][4] Leadership Perspective - The recognition as a Top Workplace reflects the dedication of Kestra's team members and their commitment to the company's mission of empowering providers and improving patient outcomes [3] - The CEO of Energage stated that earning a Top Workplaces award is a badge of honor for companies, as it comes authentically from their employees, which is crucial in today's market [4]